sorafenib has been researched along with indocyanine green in 4 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (indocyanine green) | Trials (indocyanine green) | Recent Studies (post-2010) (indocyanine green) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 9 | 0 | 2 |
| 6,520 | 730 | 5,251 | 9,939 | 589 | 5,488 |
| Protein | Taxonomy | sorafenib (IC50) | indocyanine green (IC50) |
|---|---|---|---|
| nonstructural protein 1 | Influenza A virus (A/California/07/2009(H1N1)) | 2.701 | |
| large T antigen | Betapolyomavirus macacae | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gu, D; He, J; Jin, H; Lv, Y; Qin, W; Sun, J; Sun, L; Wan, J; Wang, C; Wang, H; Wang, S; Wu, H; Yang, C; Yao, M; Yu, C; Zhang, Z | 1 |
| Chang, J; Duan, Y; Gao, JX; Gong, XQ; Hou, W; Liu, HS; Wang, HJ; Wei, D; Wu, XL; Yang, H | 1 |
| Kim, SK; Park, JS; Park, S; Park, SJ | 1 |
1 review(s) available for sorafenib and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for sorafenib and indocyanine green
| Article | Year |
|---|---|
Self-Assembled and Self-Monitored Sorafenib/Indocyanine Green Nanodrug with Synergistic Antitumor Activity Mediated by Hyperthermia and Reactive Oxygen Species-Induced Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Combined Modality Therapy; Drug Synergism; Female; Humans; Hyperthermia, Induced; Indocyanine Green; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Reactive Oxygen Species; Sorafenib | 2019 |
An NIR-responsive mesoporous silica nanosystem for synergetic photothermal-immunoenhancement therapy of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Immunotherapy; Indocyanine Green; Liver Neoplasms; Mice; Mice, Inbred C57BL; Nanoparticles; Phototherapy; Silicon Dioxide; Sorafenib; Theranostic Nanomedicine | 2020 |
Synergistic effects of concurrent photodynamic therapy with indocyanine green and chemotherapy in hepatocellular carcinoma cell lines and mouse models.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Doxorubicin; Humans; Indocyanine Green; Liver Neoplasms; Mice; Photochemotherapy; Photosensitizing Agents; Sorafenib | 2023 |